APGE is no longer listed. Its last trade on record was Sep 4, 2026. The price and figures on this page are from its last trading day and final filings, and are no longer updated.
Apogee Therapeutics, Inc. (APGE) quarterly income statement — complete revenue, gross profit & net income history
Apogee Therapeutics, Inc. (APGE) annual income statement — 4-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 408K | -400K | 400K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -408K | 400K | -400K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 96M | 82.36M | 78.46M | 70.88M | 73.17M | 63.1M | 75.88M | 58.69M | 44.12M | 38.18M | 37.16M | 24.3M | 18.89M | 12.66M | 14.1M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 24.34M | 21.55M | 20.08M | 17.1M | 17.14M | 16.57M | 15.65M | 12.97M | 10.92M | 9.46M | 8.2M | 7.24M | 4.94M | 4.2M | 1.89M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 67.3M | 60.82M | 58.44M | 54.18M | 55.7M | 46.39M | 60.23M | 45.71M | 33.21M | 28.72M | 28.95M | 17.07M | 13.95M | 8.46M | 12.21M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 0 | -68K | -400K | 325K | 143K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -96M | -82.77M | -78.06M | -71.28M | -73.17M | -63.1M | -75.88M | -58.69M | -44.12M | -38.18M | -37.16M | -24.3M | -18.89M | -12.66M | -14.1M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -31.22% | -31.18% | -2.87% | -21.46% | -65.82% | -65.25% | -104.23% | -141.46% | -133.64% | -201.64% | -163.53% | - | - | - | - |
| EBITDA | -84.2M | -82.36M | -77.65M | -70.88M | -72.77M | -62.89M | -75.81M | -58.64M | -44.09M | -38.15M | -31.73M | -20.84M | 0 | 0 | -14.01M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -15.71% | -30.97% | -2.43% | -20.87% | -65.05% | -64.84% | -138.87% | -181.37% | - | - | -126.57% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 408K | 406K | 400K | 399K | 207K | 76K | 48K | 36K | 29K | 0 | 0 | 18.89M | 12.66M | 0 |
| EBIT | -84.2M | -74.03M | -69.33M | -64.96M | -66.02M | -55.26M | -67.2M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M | -12.66M | -14.01M |
| Net Interest Income | 10.23M | 8.74M | -21.3M | 6.32M | 7.14M | 7.84M | 8.68M | 9.67M | 10.31M | 6.09M | 5.42M | 3.46M | 0 | 133K | 92K |
| Interest Income | 11.81M | 8.74M | -21.3M | 6.32M | 7.14M | 7.84M | 8.68M | 9.67M | 10.31M | 6.09M | 5.42M | 3.46M | 0 | 133K | 92K |
| Interest Expense | 1.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 10.23M | 8.74M | 8.73M | 6.32M | 7.14M | 7.84M | 8.68M | 9.67M | 10.31M | 6.09M | 5.42M | 3.46M | 0 | 133K | 92K |
| Pretax Income | -85.78M | -74.03M | -69.33M | -64.96M | -66.02M | -55.26M | -67.2M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M | -12.53M | -14.01M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 78K | 79K | 62K | 61K | 72K | 83K | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.09% | -0.11% | -0.09% | -0.09% | -0.11% | -0.15% | -0.03% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -85.85M | -74.11M | -69.39M | -65.02M | -66.1M | -55.34M | -67.22M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M | -12.53M | -14.01M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -29.89% | -33.92% | -3.23% | -32.65% | -95.46% | -72.43% | -111.81% | -135.21% | -79.06% | -156.24% | -126.57% | - | - | - | - |
| Net Income (Continuing) | -85.85M | -74.11M | -69.39M | -65.02M | -66.1M | -55.34M | -67.22M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M | -12.53M | -14.01M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 | -0.64 | -0.63 | -0.41 | -0.37 | -0.25 | -0.28 |
| EPS Growth % | -0.89% | -11.58% | 15.57% | -29.07% | -88.33% | -48.44% | -93.65% | -109.76% | -62.16% | -156% | -125% | - | - | - | - |
| EPS (Basic) | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.22 | -0.86 | -0.60 | -0.64 | -0.63 | -0.41 | -0.37 | -0.25 | -0.28 |
| Diluted Shares Outstanding | 75.44M | 69.67M | 60.69M | 58.77M | 58.43M | 58.2M | 55.19M | 56.8M | 56.52M | 50.19M | 50.66M | 50.67M | 50.67M | 50.67M | 50.67M |
| Basic Shares Outstanding | 75.44M | 69.67M | 60.69M | 58.77M | 58.43M | 58.2M | 55.19M | 56.8M | 56.52M | 50.19M | 50.66M | 50.67M | 50.67M | 50.67M | 50.67M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |